Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS)

CUSIP: 39868T105

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+4,694,552
Put/Call ratio
45%
SEC-reported price per share
$1.95
Number of holders
86
Value change
+$7,005,623
Number of buys
50
Open additional details 1 more signal available
Number of sells
52
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
160,529,963

Security key

39868T105

Report period

Q2 2023

Institutions

86

Top holders

10

Ownership snapshot

Top reported holders of GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Point72 Asset Management,...
Disclosed value leader
Point72 Asset Management,...
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

Point72 Asset Management, L.P. leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Point72 Asset Management, L.P.'s linked filing trail.
Comparable ownership Top 5
Point72 Asset Management, L.P. 4.8%
Redmile Group, LLC 4.3%
Frazier Life Sciences Management,... 3.2%
VANGUARD GROUP INC 2.3%
Versant Venture Management, LLC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Point72 Asset Management, L.P.
13F
Company
13F
4.8%
$21,350,030
7,679,867 shares
31 Mar 2023
Redmile Group, LLC
13F
Company
13F
4.3%
$19,256,854
6,926,926 shares
31 Mar 2023
Frazier Life Sciences Management, L.P.
13F
Company
13F
3.2%
$14,351,327
5,162,348 shares
31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
2.3%
$10,177,299
3,660,899 shares
31 Mar 2023
Versant Venture Management, LLC
13F
Company
13F
2.2%
$9,899,997
3,561,150 shares
31 Mar 2023
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
13F
1.5%
$6,597,023
2,373,030 shares
31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
86
Shares
50,962,397
Rows available
86
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
89
Q2 2023 holders
86
Holder diff
-3
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .